课题基金 / 基金详情

Targeting CD4-positive cells for anti-HIV gene therapy

Targeting CD4-positive cells for anti-HIV gene therapy
针对 CD4 阳性细胞进行抗 HIV 基因治疗
批准号:
nhmrc : 110211
负责人:
Prof Rodney Minchin
金额:
$23.78万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Strategic Awards
财政年份:
2000
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2000-01-01 至 2002-12-31

项目摘要

项目成果

Prof Rodney Minchin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Treatment of HIV early following infection is thought to be important for maximising the quality of life of patients. Conventional therapy has had some success in early intervention but resistance invariably develops. This application proposes to develop a gene therapy approach to elimiate HIV infected cells by introducing a suicide gene into those cells that harbor the virus. The advantage of this approach is the limited toxicity that is associated with gene therapies as well as the ability to target specific cell-types. It is proposed to genetically modify a strain of adenovirus to introduce a gene that will kill cells that it infects that also contain HIV. This is a novel approach and potentially may be an important treatment in the future. Anti-HIV gene therapy may also be useful in addition to the more conventional treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The putative drug metabolising enzyme SULT4A1 is a sulfotransferase inhibitor
  • 批准号:
    nhmrc : 1005899
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $31.2万
  • 财政年份:
    2011
  • 负责人:
    Prof Rodney Minchin
  • 依托单位:
Function of sulfotransferase SULT4A1 - transcriptional and post-transcriptional regulation
  • 批准号:
    nhmrc : 511175
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $20.14万
  • 财政年份:
    2008
  • 负责人:
    Prof Rodney Minchin
  • 依托单位:
Regulation of human arylamine N-acetyltransferase transcription, translation and protein stability
  • 批准号:
    nhmrc : 401563
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $31.4万
  • 财政年份:
    2006
  • 负责人:
    Prof Rodney Minchin
  • 依托单位:
Human arylamine N-acetyltransferase regulation and function - effect of genetic poymorphisms.
  • 批准号:
    nhmrc : 212066
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $28.14万
  • 财政年份:
    2002
  • 负责人:
    Prof Rodney Minchin
  • 依托单位:
国内基金
海外基金
梅毒螺旋体外膜蛋白Tp92经由宿主膜蛋白互作调控MYC诱导CD4⁺ T细胞衰老的分子机制
  • 批准号:
    2026JJ60545
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘兆平
  • 依托单位:
CD153 通过 NF-κB 通路调控 Mtb 特异性 CD4⁺T 细胞功能及临床转化研究
平常拟杆菌通过JAK-STAT信号通路调控初始CD4⁺T细胞CD25表达在2型糖尿病中的机制研究
自身免疫性溶血性贫血中STAT1通过UHRF1/GATA2/P300轴促进CD4细胞Th17分化机制研究
  • 批准号:
    --
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    李振江
  • 依托单位: